Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, techmover, bz777, gentle09, whento, HighYieldStocks
Search This Board: 
Last Post: 12/13/2017 9:00:55 PM - Followers: 449 - Board type: Free - Posts Today: 51



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#61919  Sticky Note Good Overview for all new investors: bz777 12/05/17 08:03:45 PM
#61908  Sticky Note For new investors: Please DD Silicon Valley biotech, gentle09 12/05/17 06:21:44 PM
#61884  Sticky Note OTCMARKETS will no longer provide quotes for aryc. lucky,mydog 12/05/17 04:08:30 PM
#61579  Sticky Note ARYC Potential revenue streams partial list: whento 12/02/17 04:18:23 PM
#59181  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 10/26/17 12:28:09 PM
#62525   Low OS....yes it is :) UndervaluedStocks 12/13/17 09:32:10 PM
#62524   Is 1 Billion shares a "low float"? MikeCr 12/13/17 09:00:55 PM
#62523   Most likely next Spring or next Summer or MikeCr 12/13/17 08:59:58 PM
#62522   It will be our Christmas present from Rene UndervaluedStocks 12/13/17 08:21:57 PM
#62521   100% correct. This is following the same pattern ROSECITY 12/13/17 08:18:29 PM
#62520   well any feelings on release of fins. End 0cash 12/13/17 07:41:01 PM
#62519   Agreed. Mykkus 12/13/17 05:03:38 PM
#62518   Spot on. Getting the same feeling with this one. SK510 12/13/17 03:10:28 PM
#62517   My sentiments as well. whento 12/13/17 03:05:37 PM
#62515   I agree hold long here Penny Traders Club 12/13/17 02:25:35 PM
#62514   Building a solid base at these levels. I millionaireonpaper 12/13/17 02:02:33 PM
#62513   Agree great post. Just show us him much Penny Traders Club 12/13/17 01:51:04 PM
#62511   Great post SK510 12/13/17 01:12:41 PM
#62510   NEW tweet...Arrayit quotes $1,500,000 microarray consumables sale to HighYieldStocks 12/13/17 01:07:41 PM
#62509   Nasdaq ??? You are joking ?? This company Hugie 12/13/17 12:57:46 PM
#62508   NEW tweet...Arrayit clinical team receives invitation from Director HighYieldStocks 12/13/17 12:43:45 PM
#62507   NEW tweet...Arrayit science team receives publication invitation from HighYieldStocks 12/13/17 12:43:17 PM
#62506   NEW tweet...Arrayit reports microarray services request for Singaporean HighYieldStocks 12/13/17 12:43:05 PM
#62505   NEW tweet...Arrayit reports microarray instrument request from world HighYieldStocks 12/13/17 12:42:53 PM
#62504   NEW tweet...Arrayit ships microarray consumables sale to the HighYieldStocks 12/13/17 12:42:45 PM
#62503   ARYC is a real, state of the art UndervaluedStocks 12/13/17 12:40:48 PM
#62502   If they do not release the fins by Hugie 12/13/17 12:31:51 PM
#62501   .009’s getting taken out :) UndervaluedStocks 12/13/17 12:30:30 PM
#62500   It is not very probable that the fins Hugie 12/13/17 12:29:40 PM
#62498   i understand. And yes the foot has been whento 12/13/17 11:46:35 AM
#62497   I have been in this for years. I kittie88 12/13/17 11:43:40 AM
#62496   NEW tweet...Arrayit ships microarray consumables sale to top HighYieldStocks 12/13/17 11:33:07 AM
#62495   Upon the final completion of the audited financials UndervaluedStocks 12/13/17 11:30:42 AM
#62493   And once we get current updates on contracts whento 12/13/17 11:27:22 AM
#62492   Arrayit reports $168,000 microarray instrument sale to top UndervaluedStocks 12/13/17 11:25:09 AM
#62491   Arrayit company newsletter features serum separation blood card UndervaluedStocks 12/13/17 11:23:28 AM
#62490   And those are just the tweeted sales. gentle09 12/13/17 11:21:50 AM
#62489   Link to their products: UndervaluedStocks 12/13/17 11:21:28 AM
#62488   ?$20,000 + in sales every day ? UndervaluedStocks 12/13/17 11:20:22 AM
#62487   This list is what has so many people SK510 12/13/17 11:18:00 AM
#62486   Yep, quite possible on one or two occasions jrsh 12/13/17 11:15:40 AM
#62485   no. lucky,mydog 12/13/17 11:10:33 AM
#62484   Did you ever think maybe they were just bz777 12/13/17 11:03:43 AM
#62483   You really believe they will reveal the big jrsh 12/13/17 10:45:39 AM
#62481   Google Arrayit President Mark Schena and you will UndervaluedStocks 12/13/17 10:31:37 AM
#62480   Dear Rene and Mark, Thank you for all bz777 12/13/17 10:22:31 AM
#62479  Restored I'm surprised Mark's resume still has this hilarious MikeCr 12/13/17 10:19:44 AM
#62478  Restored Google Arrayit President Mark Schena and you will UndervaluedStocks 12/13/17 09:28:12 AM
#62477   ARYC Potential revenue streams partial list: bz777 12/13/17 09:27:56 AM
#62476   Daily SALES, daily REVENUES, open communication, multilayered business HighYieldStocks 12/13/17 02:09:30 AM
#62474   Either trust in the company or don't. TravO 12/12/17 11:45:32 PM
#62473   not sure " everyone else " has quite hbhmb 12/12/17 11:34:36 PM
#62472   Please everyone, do your due diligence on ARYC...... UndervaluedStocks 12/12/17 10:06:05 PM
#62471   Thank you sir. Yes, waiting until after everyone UndervaluedStocks 12/12/17 09:21:22 PM
#62470   you advised of this stock a month or hbhmb 12/12/17 09:02:22 PM